The editors are convinced that the problem of DIDs is growing worse as more and more drugs come on the market and as our population ages, says Miller. ???We encourage a heightening effort to report adverse drug events, including the subset of events that are drug-induced,??? he says. ???Claims data could be invaluable in such an effort, especially if plans and PBMs were to take the initiative.???